HPV Vaccine and HPV Associated Cancers


diamonds

Current Programs


  • HPV Moon Shot - Flagship 1: Prevention

    The aims of the prevention moon shot are:

    • Educate healthcare professionals to increase HPV vaccination rates and reduce missed clinical opportunities to recommend and administer HPV vaccines.

    • Develop a mass-reach communications campaign targeting healthcare providers in order to increase awareness of the need for HPV vaccinations.

    • Work with Texas stakeholders to discuss HPV issues in Texas, increasing vaccination rates and to assist in the development of content and protocols for providing training to Texas healthcare providers.

    • Develop special outreach programs to reach MD Anderson employees, faith-based communities, stem-cell transplant patients, HIV patients and middle school administrators.

    • Create a dynamic economic impact model that will forecast the oropharyngeal cancer (OPC) incidence among men and the cervical cancer incidence among women in Texas.

    For additional information, dowload the handout, below.

HPV Moon Shot Flagship 1 Prevention handout




diamonds


Educational Materials & Resources

Videos

State Partner HPV Activities

News


diamonds


HPV Fact Sheet (English)   Updated January 2017!

HPV Fact Sheet

diamonds


HPV Fact Sheet (Spanish) - Hoja Informativa del HPV   Updated!

Hoja Informativa del HPV

diamonds


HPV Frequently Asked Questions (FAQ) Sheet   
Updated January 2017!

HPV FAQ

diamonds


HPV Resource Kit   Updated!

The University of Texas MD Anderson Cancer Center has compiled resources that may be used to increase HPV vaccination. These resources were gathered from a variety of sources, are all public domain, and may be used by anyone.

diamonds


HPV by the numbers   Infographic

HPV by the Numbers

diamonds


Educational Poster: Don’t Wait, Vaccinate!/¡No espere, vacúnelos!

HPV Vaccine Poster

diamonds


HPV: What Every Parent Should Know

HPV: What Every Parent Should Know

diamonds


Protect Your Daughter and Son Against Cancer (English/Spanish)

Protect

diamonds


Get the 3 HPV Vaccine Shots (Vietnamese)

Cervical Cancer: Reduce Your Risk

diamonds


Cervical Cancer: Reduce Your Risk

Cervical Cancer: Reduce Your Risk

diamonds


Oropharyngeal Cancer and the Human Papillomavirus (HPV): Questions and Answers

Oropharyngeal Cancer and the Human Papillomavirus (HPV): Questions and Answers

diamonds


8 Ways to Reduce Your Cancer Risk

8 Ways to Reduce Your Cancer Risk

diamonds


2015 Summit on HPV-Related Diseases  (presentations)

The 2015 HPV Summit was a big success! Topics included raising awareness of HPV-associated cancers and diseases prevention and screening, raising awareness of HPV vaccinations for adolescents, and identifying barriers and resources to help children receive needed HPV vaccines. Learn more...

diamonds


HPV Vaccine Uptake in Texas Pediatric Care Settings: 2014-2015 Environmental Scan Report

The University of Texas MD Anderson Cancer Center in Houston has conducted a detailed assessment or "environmental scan" on HPV vaccination in pediatric care settings in Texas. The report provides an overview of HPV-related cancer burden in Texas and identifies barriers to and facilitators of HPV vaccination in the pediatric population as observed by Texas stakeholders. This project was funded by a grant from the National Cancer Institute.

MD Anderson hopes that the findings and recommendations will assist your organization in developing strategies to increase HPV vaccine uptake, enhance existing collaborations, and prevent potentially avoidable cancer diagnoses and deaths related to HPV infections.

MD Anderson is committed to helping to eradicate the HPV-related disease burden and is utilizing the data collected to drive the institutional HPV moonshot efforts and to help establish a coalition across Texas in partnership with the Centers of Disease Control (CDC), Texas Pediatric Society (TPS), Texas Medical Association (TMA) and the Department of State Health Services (DSHS).

To view/download the report, click on one of the following links.


HPV Environmental Scan Report

diamonds


Project ECHO® at MD Anderson

Project ECHO® was developed in 2003 by Dr. Sanjeev Arora of the University of New Mexico in response to a high prevalence of untreated Hepatitis C (HCV) in the state. Using this model, Dr. Arora conducted a prospective clinical trial, the results of which were published in 2011 in the New England Journal of Medicine. Dr. Arora conducted weekly videoconferences with primary care providers in 16 community clinics and 5 prisons in New Mexico. Patient cases were presented, and a multidisciplinary team at the UNM provided clinical mentoring, evidence-based advice on patient management and regular didactic education sessions. At the end of the study period, the outcomes of patients treated by specialists at UNM were compared with those of patients treated by primary care providers. The study found no significant differences in sustained viral response between the UNM cohort and the ECHO cohort. The study concluded that the ECHO model is safe and effective in treating HCV in underserved communities.

The Project ECHO model has since expanded to more than 87 hubs worldwide for nearly 30 diseases and conditions. These specialties include infectious diseases, rheumatologic diseases, chronic pain, addiction, HIV diabetes, complex multisystem disease, cancer prevention and hospice care. The VA, DOD and CDC have ongoing ECHO clinics. At MD Anderson projects are currently focused on Cervical Cancer Prevention, Management of Cervical and Breast Cancer, Tobacco Cessation for Mental Health centers, Survivorship, Palliative Care and Pathology. Visit the Project ECHO website at http://www.mdanderson.org/projectECHO to learn more.


Project ECHO at MD Anderson flyer

diamonds


NCI-designated Cancer Centers Urge HPV Vaccination for the Prevention of Cancer

NCI-designated Cancer Centers HPV statement

diamonds


American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention

Abstract: American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such will promote underused interventions that have the potential to save millions of lives through cancer prevention. As the main providers of cancer care worldwide, our patients, their families, and our communities look to us for guidance regarding all things cancer related, including cancer prevention. Through this statement and accompanying recommendations, ASCO hopes to increase awareness of the tremendous global impact of human papillomavirus (HPV) –caused cancers, refocus the discussion of HPV vaccination on its likely ability to prevent millions of cancer deaths, and increase HPV vaccination uptake via greater involvement of oncology professionals in ensuring accurate public discourse about HPV vaccination and calling for the implementation of concrete strategies to address barriers to vaccine access and acceptance.

See more at http://jco.ascopubs.org/content/early/2016/04/07/JCO.2016.67.2014.full.

diamonds


Administrative Supplements for NCI-Designated Cancer Centers to Support Collaborations to Enhance HPV Vaccination in Pediatric Settings: A Summary Report, June 2016

NCI Administrative Supplements

diamonds


Videos


Rice University’s Baker Institute for Public Policy, Panel Discussion, December 2, 2016 - HPV-Related Cancers: Opportunities for Cancer Prevention   New!

In the United States, 79 million men and women — approximately one in four — are currently infected with the human papillomavirus (HPV). From 2008 to 2012, nearly 40,000 HPV-related cancers occurred annually in the United States. Today, highly effective HPV vaccines could easily reduce these numbers, but only 42 percent of girls and 28 percent of boys aged 13 to 17 have received the vaccine — far below the 80 percent of American adolescents the Centers for Disease Control and Prevention (CDC) aim to reach. At this event, leaders from the CDC, Texas state government and The University of Texas MD Anderson Cancer Center discussed HPV, HPV-associated cancers, life-saving cancer prevention opportunities through HPV vaccination, barriers to HPV vaccination programs and a proposed plan to promote HPV vaccination in Texas.

This panel discussion was the eighth event in the Medicine, Research and Society Policy Issues Series, a joint project of the Baker Institute Center for Health and Biosciences and The University of Texas MD Anderson Cancer Center.



diamonds


Confronting Cancer: MD Anderson supports the HPV vaccine

MD Anderson supports the HPV vaccine for the prevention of several types of cancer. Learn more at MakingCancerHistory.com/HPV.



diamonds


MD Anderson Cancer Center Video - Why my kids get the HPV vaccine: A cervical cancer survivor’s story

As a cervical cancer survivor and parent to two sons, Linda Ryan advises other parents to vaccinate their kids against the human papillomavirus (HPV). She wishes the HPV vaccine had been available to her as an adolescent so she could have avoided cervical cancer, which is predominantly caused by HPV.



diamonds


MD Anderson Cancer Center Video - Cancer survivor Kara Million on the importance of HPV vaccinations

Cancer survivor Kara Million was diagnosed with cervical cancer, which was caused by the human papillomavirus (HPV) infection. She is now an advocate for the HPV vaccine. Watch as she shares her story and urges everyone to protect their children with the HPV vaccine.



diamonds


American Cancer Society HPV Cancer Survivor Videos

Twelve videos from survivors of HPV-related cancers. (American Cancer Society)



diamonds



State Partner HPV Activities


American Cancer Society HPV VACs Partner Newsletter, June 2016

>American Cancer Society HPV VACs Partner Newsletter, June 2016